Enova International, Inc.
ENVA
$237.39
-6.68%
Enova International, Inc. is a technology-enabled financial services company providing online short-term consumer loans, lines of credit, and installment loans primarily in the United States and Brazil, with a money transfer platform under the Pangea brand. It operates as a leading fintech lender in the alternative credit space, leveraging proprietary analytics and automated underwriting to serve consumers and small businesses underserved by traditional banks. The current investor narrative centers on Enova's robust revenue growth and margin expansion, driven by strong demand for its credit products and operational leverage, while the stock has surged over 140% in the past year, reflecting optimism about its scalable platform and improving credit performance. However, concerns about regulatory scrutiny in the consumer lending industry and the sustainability of growth in a potentially softening credit environment remain key debates.…
ENVA
Enova International, Inc.
$237.39
Investment Opinion: Should I buy ENVA Today?
Based on the analysis, ENVA is rated a Buy. The company's strong revenue growth of 17.4% YoY, improving profitability, and low valuation (PE 12.8x, PEG 0.22) support this rating. The consensus analyst target of $277.14 implies 4.4% upside, but the high target of $300 suggests more potential. Key supporting data points include: revenue growth accelerating from $628M in Q2 2024 to $875M in Q1 2026, net income rising to $91M, operating margin of 23.5%, and free cash flow of $1.86B TTM. The stock is trading at a discount to its growth rate, making it attractive for growth investors.
Sign up to view all
ENVA 12-Month Price Forecast
The AI assessment is bullish on ENVA due to its strong growth, improving profitability, and attractive valuation. The low PEG ratio suggests the market is not fully pricing in future earnings growth. However, the high debt levels and regulatory risks temper confidence. If the company can maintain its growth trajectory and manage credit risk, the stock has significant upside potential. A downgrade to neutral would occur if revenue growth decelerates below 10% or credit losses rise materially.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Enova International, Inc.'s 12-month outlook, with a consensus price target around $277.14 and implied upside of +16.8% versus the current price.
Average Target
$277.14
0 analysts
Implied Upside
+16.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$257 - $300
Analyst target range
Enova is covered by 7 analysts, with a consensus recommendation leaning bullish, as recent ratings from firms like Jefferies, TD Cowen, and BTIG are all 'Buy' or 'Market Outperform'. The average target price is $277.14, implying an upside of approximately 4.4% from the current price of $265.45. The target range spans from $257.00 (low) to $300.00 (high), with the high target suggesting potential for further upside if the company sustains its growth trajectory, while the low target reflects concerns about regulatory or credit risks. The relatively narrow spread between the low and high targets (about 16.7% from the average) indicates moderate conviction among analysts, with no recent downgrades, as all institutional ratings actions have been reaffirmations of Buy or Outperform.
Bulls vs Bears: ENVA Investment Factors
Enova presents a compelling growth story with strong revenue acceleration, improving margins, and a low valuation relative to its growth rate. The bull case is supported by robust fundamentals and positive analyst sentiment, while the bear case highlights high leverage, regulatory risks, and limited near-term upside. Currently, the bull case has stronger evidence given the company's consistent execution and attractive PEG ratio. The key tension is whether Enova can sustain its growth and credit quality in a potentially softening economy, which would determine if the low PE is justified or a value trap.
Bullish
- Strong Revenue Growth: Q1 2026 revenue grew 17.4% YoY to $875.1M, with sequential acceleration from $839.4M in Q4 2025 and $802.7M in Q3 2025. This consistent growth over eight quarters demonstrates robust demand for Enova's credit products.
- Improving Profitability: Net income rose to $91.1M in Q1 2026 from $78.9M in Q4 2025, with operating margin expanding to 23.5% from 22.2%. The company's net margin of 9.8% reflects operational leverage as revenue scales.
- Attractive Valuation: Trailing PE of 12.8x and forward PE of 12.9x are low for a company growing revenue at 17%+, with a PEG ratio of 0.22 indicating significant undervaluation relative to growth. This suggests the market is not fully pricing in future earnings potential.
- Positive Analyst Sentiment: All 7 analysts rate ENVA as Buy or Outperform, with an average target of $277.14, implying 4.4% upside. The high target of $300 suggests potential for 13% upside if growth continues.
Bearish
- High Debt Levels: Debt-to-equity ratio of 3.41x is elevated, reflecting significant leverage used to fund lending operations. This increases financial risk, especially if credit conditions deteriorate.
- Regulatory Risk: Enova operates in the consumer lending space, which is subject to intense regulatory scrutiny. Changes in laws governing interest rates or lending practices could materially impact operations and profitability.
- Limited Analyst Upside: Average analyst target of $277.14 is only 4.4% above the current price, suggesting limited upside potential in the near term. The low target of $257 implies a potential 3.2% downside.
- Low Current Ratio: Current ratio of 0.23 indicates potential liquidity concerns, as current assets are insufficient to cover short-term liabilities. This could strain operations if funding markets tighten.
ENVA Technical Analysis
Enova's stock is in a powerful sustained uptrend, with a 1-year price change of +141.1% and a 6-month change of +78.0%, far outpacing the S&P 500's 20.4% gain over the same period. The current price of $265.45 sits just 0.7% below the 52-week high of $267.45, indicating the stock is trading at the upper end of its 52-week range (approximately 99% of the range). This positioning near highs reflects strong momentum and investor confidence, though it also raises the risk of short-term overextension and potential profit-taking.
Beta
1.23
1.23x market volatility
Max Drawdown
-24.8%
Largest decline past year
52-Week Range
$103-$267
Price range past year
Annual Return
+120.4%
Cumulative gain past year
| Period | ENVA Return | S&P 500 |
|---|---|---|
| 1m | +3.9% | +1.9% |
| 3m | +50.7% | +2.3% |
| 6m | +63.3% | +10.6% |
| 1y | +120.4% | +19.5% |
| ytd | +46.6% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ENVA Fundamental Analysis
Enova's revenue trajectory is accelerating, with Q1 2026 revenue of $875.1 million, up 17.4% year-over-year, and sequential growth from $839.4 million in Q4 2025 and $802.7 million in Q3 2025. The company has consistently grown revenue over the past eight quarters, from $628.4 million in Q2 2024 to the current level, indicating a robust growth trend driven by strong demand for its credit products and expansion in its markets. This growth is supported by a net income of $91.1 million in Q1 2026, up from $78.9 million in Q4 2025, reflecting improving profitability as the company scales.
Quarterly Revenue
$875142000.0B
2026-03
Revenue YoY Growth
+17.4%
YoY Comparison
Gross Margin
99.0%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ENVA Overvalued?
Given Enova's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 12.82x, while the forward PE is 12.89x, indicating that the market expects earnings to remain stable, with a negligible difference between trailing and forward multiples. This suggests that the current valuation already incorporates near-term earnings expectations, and any upside would require earnings growth to exceed current estimates.
PE
12.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant due to Enova's high leverage, with a debt-to-equity ratio of 3.41x. This leverage amplifies the impact of credit losses and interest rate changes on earnings. The current ratio of 0.23 indicates potential liquidity stress, as the company relies heavily on short-term funding to support its lending activities. While free cash flow is strong at $1.86B TTM, a sudden tightening in credit markets could constrain operations. Additionally, the company's net margin of 9.8% is relatively thin, leaving limited buffer against adverse credit events.
FAQ
The key risks include: 1) High leverage (debt-to-equity of 3.41x) which amplifies losses in a downturn; 2) Regulatory risk, as consumer lending is heavily scrutinized and new rules could limit profitability; 3) Credit risk, as a lender to subprime consumers, defaults could rise in an economic slowdown; 4) Liquidity risk, with a current ratio of 0.23, the company relies on external funding. The most severe risk is a combination of economic recession and regulatory changes, which could significantly impact earnings and the stock price.
The 12-month forecast for ENVA is moderately bullish. The base case scenario, with a 50% probability, expects the stock to trade around $277, in line with the analyst average target. The bull case, with a 30% probability, could see the stock reach $300+ if growth accelerates and margins expand. The bear case, with a 20% probability, could see the stock fall to $230-260 if credit conditions deteriorate. Overall, the most likely outcome is modest upside, with the stock trading in a range of $265-285 over the next year.
ENVA appears undervalued relative to its growth rate. The trailing PE of 12.8x is low for a company growing revenue at 17.4% YoY, and the PEG ratio of 0.22 is well below the typical threshold of 1, indicating the stock is cheap relative to its earnings growth. Compared to the broader financial sector, ENVA trades at a discount. The market seems to be pricing in concerns about credit quality and regulatory risks, but if the company continues to execute, the valuation could re-rate higher. Overall, the stock is undervalued based on current fundamentals.
ENVA is a good buy for investors seeking growth at a reasonable price, given its PEG of 0.22 and PE of 12.8x. The stock has strong momentum, with a 141% gain over the past year, and analysts are bullish with a consensus Buy rating. However, the average target implies only 4.4% upside, so near-term gains may be limited. The biggest risk is a credit downturn that could hurt earnings. For long-term investors with a 3-5 year horizon, ENVA offers attractive growth potential, but it is not without risk.
ENVA is more suitable for long-term investment, given its growth trajectory and attractive valuation. The stock has a beta of 1.23, indicating higher volatility than the market, which could lead to significant short-term swings. However, the company's strong fundamentals, such as 17.4% revenue growth and improving margins, suggest that holding for at least 3-5 years could allow the investment to compound. Short-term traders might find opportunities given the momentum, but the limited analyst upside (4.4%) suggests near-term gains may be capped. For long-term investors, ENVA offers a compelling growth story at a reasonable price.